Snowden Capital Advisors’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-5,182	Closed	-$265K	–	1213
2024 Q4	$265K	Buy	5,182 +39	+0.8%	+$1.99K	0.01%	1045
2024 Q3	$263K	Buy	5,143 +109	+2%	+$5.57K	0.01%	1066
2024 Q2	$225K	Sell	5,034 -101	-2%	-$4.52K	0.01%	1093
2024 Q1	$240K	Buy	+5,135	New	+$240K	0.01%	1059